Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.56 |
| ▸ | MAOA | P21397 | 5/20 | 0.53 |
| ▸ | MAOB | P27338 | 5/20 | 0.53 |
| ▸ | GRM5 | P41594 | 1/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.50 |
| ▸ | MPO | P05164 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | QPCT | Q16769 | 1/20 | 0.50 |
| ▸ | IP6K2 | Q9UHH9 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | CA12 | O43570 | 2/20 | 0.49 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29799642 | 1.00 | FTO (1.00) | FTOKDM4EMAOAMAOBGRM5 | |
| Methylene Chloride SCHEMBL27891472 | 0.94 | FTO (0.89) | FTOKDM4EMAOAMAOBGRM5 | |
| SCHEMBL7617877 | 0.84 | FTO (0.72) | FTOMAOAMAOBALDH1A1SMN1; SMN2 | |
| Ethoxycarbonyl Group SCHEMBL27476972 | 0.82 | FTO (0.68) | FTOKDM4EMAOAMAOBGRM5 | |
| SCHEMBL15346102 | 0.79 | FTO (0.66) | FTOKDM4EMAOAMAOBGRM5 | |
| SCHEMBL28230155 | 0.78 | FTO (0.63) | FTOKDM4EMAOAMAOBGRM5 | |
| SCHEMBL3681299 | 0.76 | FTO (0.61) | FTOKDM4EMAOAMAOBGRM5 | |
| SCHEMBL30771801 | 0.76 | FTO (0.61) | FTOKDM4EMAOAMAOBGRM5 | |
| SCHEMBL17708837 | 0.76 | FTO (0.61) | FTOKDM4EMAOAMAOBGRM5 | |
| SCHEMBL903208 | 0.76 | FTO (0.61) | FTOKDM4EMAOAMAOBGRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 309 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12594421-B2 | Compositions and methods for increasing cancer cell sensitivity to alternating electric fields | NOVOCURE GMBH (CH) | 2026-04-07 | — | — | US | claimed |
| US-20260091047-A1 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | NATIVE CODE BIO LLC (US) | 2026-04-02 | — | — | US | claimed |
| EP-4583856-A2 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | Native Code Bio, LLC (US) | 2025-07-16 | — | — | EP | claimed |
| CN-116239557-B | Compound containing 7-hydroxy chromone structure and preparation method and application thereof | 深圳万知达企业管理有限公司 | 2025-02-18 | — | — | CN | claimed |
| WO-2024182413-A1 | THERAPEUTIC METHODS | SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE (US) | 2024-09-06 | — | — | WO | claimed |
| WO-2024054688-A2 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | NATIVE CODE BIO, LLC (US) | 2024-03-14 | — | — | WO | claimed |
| CN-116239557-A | Compound containing 7-hydroxy chromone structure and preparation method and application thereof | 广东轻工职业技术学院 | 2023-06-09 | — | — | CN | claimed |
| EP-4188380-A1 | COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | Novocure GmbH (CH) | 2023-06-07 | — | — | EP | claimed |
| US-20220096818-A1 | Compositions And Methods For Increasing Cancer Cell Sensitivity To Alternating Electric Fields | BIOPHARMA CREDIT PLC (GB) | 2022-03-31 | — | — | US | claimed |
| WO-2022029628-A1 | COMPOSITIONS AND METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2022-02-10 | — | — | WO | claimed |
| US-20080003300-A1 | Compostions containing Mg/Zn/F-CaP plus inhibitors of pro-inflammatory Cytokines (a combination of a Free-B-Ring flavonoids and a flavan) for osteoporosis prevention, therapy and treatment of bone diseases | GAFFAR MARIA C | 2008-01-03 | — | — | US | claimed |
| CN-101083981-A | Flavonoid composition for treating oral diseases | UNIGEN PHARMACEUTICALS INC (US) | 2007-12-05 | — | — | CN | claimed |
| EP-1804787-A2 | FLAVONOID COMPOSITION FOR TREATING ORAL DISEASES | Unigen Pharmaceuticals, Inc. (US) | 2007-07-11 | — | — | EP | claimed |
| WO-2006045056-A2 | FLAVONOID COMPOSITION FOR TREATING ORAL DISEASES | UNIGEN PHARMACEUTICALS, INC. (US) | 2006-04-27 | — | — | WO | claimed |
| US-20060079467-A1 | administering plants extracts which inhibits cyclooxygenases and lipoxygenases, and reduces cytokine production; periodontal diseases | UNIGEN PHARMACEUTICALS, INC. (US) | 2006-04-13 | — | — | US | claimed |
| US-20050164957-A1 | 7-Hydroxy chromones as potent antioxidants | UNIGEN PHARMACEUTICALS, INC. (US) | 2005-07-28 | — | — | US | claimed |
| US-6884783-B2 | 7-Hydroxy chromones as potent antioxidants | UNIGEN PHARMACEUTICALS, INC. (US) | 2005-04-26 | — | — | US | claimed |
| EP-1503777-A1 | 7-HYDROXY CHROMONES AS POTENT ANTIOXIDANTS | Unigen Pharmaceuticals, Inc. (US) | 2005-02-09 | — | — | EP | claimed |
| WO-2003092713-A1 | 7-HYDROXY CHROMONES AS POTENT ANTIOXIDANTS | UNIGEN PHARMACEUTICALS, INC. (US) | 2003-11-13 | — | — | WO | claimed |
| US-20030207818-A1 | Identification and purification of 7-hydroxychromes that exhibit potent antioxidant activity. In one embodiment the present invention includes a method for providing an antioxidant to a host in need thereof, comprising | UNIGEN, INC. | 2003-11-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080003300-A1 | Compostions containing Mg/Zn/F-CaP plus inhibitors of pro-inflammatory Cytokines (a combination of a Free-B-Ring flavonoids and a flavan) for osteoporosis prevention, therapy and treatment of bone diseases | IL1B, TNF, SLC30A6 | FTO 4044/4885KDM4E 4405/4885MAOA 347/4885 |
| US-20260091047-A1 | THERAPEUTIC COMBINATIONS FOR MOVEMENT DISORDERS | HMBS, SNCA, PYGB | FTO 117/4885KDM4E 1322/4885MAOA 229/4885 |
| US-20060079467-A1 | administering plants extracts which inhibits cyclooxygenases and lipoxygenases, and reduces cytokine production; periodontal diseases | LPO, GLA, LOX | FTO 3580/4885KDM4E 3660/4885MAOA 200/4885 |
| US-12594421-B2 | Compositions and methods for increasing cancer cell sensitivity to alternating electric fields | PTK2, GSK3B, MTOR | FTO 2908/4885KDM4E 2098/4885MAOA 4340/4885 |
| US-20030207818-A1 | Identification and purification of 7-hydroxychromes that exhibit potent antioxidant activity. In one embodiment the present invention includes a method for providing an antioxidant to a host in need thereof, comprising | NQO1, KEAP1, NOX4 | FTO 407/4885KDM4E 2040/4885MAOA 269/4885 |
| US-20050164957-A1 | 7-Hydroxy chromones as potent antioxidants | CYP27A1, NOX4, ROS1 | FTO 1117/4885KDM4E 2448/4885MAOA 330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.